Beam Therapeutics (BEAM) Competitors $19.89 +0.76 (+3.95%) Closing price 03:58 PM EasternExtended Trading$19.82 -0.06 (-0.30%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BEAM vs. RVMD, BBIO, TGTX, LEGN, TLX, SRPT, BPMC, AXSM, NUVL, and ADMAShould you be buying Beam Therapeutics stock or one of its competitors? The main competitors of Beam Therapeutics include Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), Legend Biotech (LEGN), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Sarepta Therapeutics (SRPT), Blueprint Medicines (BPMC), Axsome Therapeutics (AXSM), Nuvalent (NUVL), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. Beam Therapeutics vs. Revolution Medicines BridgeBio Pharma TG Therapeutics Legend Biotech Telix Pharmaceuticals Limited American Depositary Shares Sarepta Therapeutics Blueprint Medicines Axsome Therapeutics Nuvalent ADMA Biologics Beam Therapeutics (NASDAQ:BEAM) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment. Do analysts rate BEAM or RVMD? Beam Therapeutics presently has a consensus price target of $49.45, indicating a potential upside of 148.70%. Revolution Medicines has a consensus price target of $66.67, indicating a potential upside of 77.83%. Given Beam Therapeutics' higher probable upside, equities research analysts plainly believe Beam Therapeutics is more favorable than Revolution Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beam Therapeutics 0 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 2 Strong Buy rating(s) 3.00Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is BEAM or RVMD more profitable? Revolution Medicines has a net margin of 0.00% compared to Beam Therapeutics' net margin of -41.07%. Beam Therapeutics' return on equity of -16.22% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Beam Therapeutics-41.07% -16.22% -10.94% Revolution Medicines N/A -33.67%-30.08% Which has more volatility and risk, BEAM or RVMD? Beam Therapeutics has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Which has preferable earnings and valuation, BEAM or RVMD? Beam Therapeutics has higher revenue and earnings than Revolution Medicines. Revolution Medicines is trading at a lower price-to-earnings ratio than Beam Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeam Therapeutics$63.52M31.24-$132.53M-$4.58-4.34Revolution Medicines$742K9,393.37-$436.37M-$3.57-10.50 Does the media prefer BEAM or RVMD? In the previous week, Revolution Medicines had 2 more articles in the media than Beam Therapeutics. MarketBeat recorded 8 mentions for Revolution Medicines and 6 mentions for Beam Therapeutics. Revolution Medicines' average media sentiment score of 1.71 beat Beam Therapeutics' score of 0.52 indicating that Revolution Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beam Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Revolution Medicines 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Does the MarketBeat Community believe in BEAM or RVMD? Revolution Medicines received 31 more outperform votes than Beam Therapeutics when rated by MarketBeat users. Likewise, 76.98% of users gave Revolution Medicines an outperform vote while only 58.93% of users gave Beam Therapeutics an outperform vote. CompanyUnderperformOutperformBeam TherapeuticsOutperform Votes6658.93% Underperform Votes4641.07% Revolution MedicinesOutperform Votes9776.98% Underperform Votes2923.02% Do institutionals and insiders believe in BEAM or RVMD? 99.7% of Beam Therapeutics shares are held by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are held by institutional investors. 4.2% of Beam Therapeutics shares are held by company insiders. Comparatively, 8.0% of Revolution Medicines shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryRevolution Medicines beats Beam Therapeutics on 10 of the 18 factors compared between the two stocks. Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BEAM vs. The Competition Export to ExcelMetricBeam TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.98B$2.90B$5.35B$7.51BDividend YieldN/A1.91%5.44%4.34%P/E Ratio-11.3030.5321.9718.05Price / Sales31.24476.12396.62104.31Price / CashN/A168.6838.2034.62Price / Book1.653.716.734.14Net Income-$132.53M-$72.06M$3.21B$247.59M7 Day Performance19.65%10.86%6.42%6.27%1 Month Performance-14.66%-8.12%-5.85%-3.48%1 Year Performance-15.27%-22.27%15.28%2.86% Beam Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BEAMBeam Therapeutics2.8107 of 5 stars$19.89+3.9%$49.45+148.7%-20.6%$1.98B$63.52M-11.30510Options VolumeGap UpRVMDRevolution Medicines3.8588 of 5 stars$36.47+2.1%$66.67+82.8%+1.2%$6.78B$742,000.00-10.16250News CoveragePositive NewsGap UpBBIOBridgeBio Pharma4.5556 of 5 stars$34.85+2.8%$52.64+51.0%+36.3%$6.63B$221.90M-12.23400News CoveragePositive NewsTGTXTG Therapeutics3.356 of 5 stars$38.41+4.6%$40.67+5.9%+169.4%$6.03B$329.00M-384.06290Upcoming EarningsNews CoveragePositive NewsGap UpLEGNLegend Biotech2.1944 of 5 stars$32.11+0.3%$79.00+146.0%-26.7%$5.90B$627.24M-33.801,070Analyst ForecastTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.84+1.1%$22.00+30.6%N/A$5.69B$783.21M0.00N/AGap UpSRPTSarepta Therapeutics4.6474 of 5 stars$54.63+7.1%$161.83+196.2%-49.3%$5.30B$1.90B43.70840Analyst ForecastShort Interest ↑Gap UpBPMCBlueprint Medicines2.4526 of 5 stars$82.53+2.1%$124.95+51.4%-7.9%$5.27B$508.82M-76.42640News CoverageGap UpAXSMAxsome Therapeutics4.5254 of 5 stars$103.53+5.6%$169.80+64.0%+46.0%$5.05B$385.69M-17.28380NUVLNuvalent1.8222 of 5 stars$70.00+5.6%$113.44+62.1%+10.7%$5.01BN/A-20.1740News CoveragePositive NewsGap UpADMAADMA Biologics1.8453 of 5 stars$20.91+7.8%$22.50+7.6%+245.0%$4.94B$426.45M74.68530News CoveragePositive NewsGap Up Related Companies and Tools Related Companies RVMD Alternatives BBIO Alternatives TGTX Alternatives LEGN Alternatives TLX Alternatives SRPT Alternatives BPMC Alternatives AXSM Alternatives NUVL Alternatives ADMA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BEAM) was last updated on 4/23/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BEAM Stock Free BEAM Stock Alerts